186 related articles for article (PubMed ID: 6193123)
1. Adjuvant chemotherapy in osteosarcoma - effects of cisplatinum, BCD, and fibroblast interferon in sequential combination with HD-MTX and adriamycin. Preliminary results of the COSS 80 study.
Winkler K; Beron G; Kotz R; Salzer-Kuntschik M; Beck J; Beck W; Brandeis W; Ebell W; Erttmann R; Göbel U; Havers W; Henze G; Hinderfield L; Höcker P; Jobke A; Jürgens H; Kabisch H; Landbeck G; Preusser P; Prindull G; Ramach W; Ritter J; Sekera J; Treuner J; Wüst G
J Cancer Res Clin Oncol; 1983; 106 Suppl():1-7. PubMed ID: 6193123
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.
Winkler K; Beron G; Delling G; Heise U; Kabisch H; Purfürst C; Berger J; Ritter J; Jürgens H; Gerein V
J Clin Oncol; 1988 Feb; 6(2):329-37. PubMed ID: 2448428
[TBL] [Abstract][Full Text] [Related]
3. [Results of the COSS-77 and COSS-80 studies on adjuvant chemotherapy in osteosarcoma of the extremities].
Purfürst C; Beron G; Torggler S; Kotz R; Salzer-Kuntschik M; Winkler K
Klin Padiatr; 1985; 197(3):233-8. PubMed ID: 2409325
[TBL] [Abstract][Full Text] [Related]
4. Treatment of osteosarcoma: experience of the Cooperative Osteosarcoma Study Group (COSS).
Winkler K; Bielack SS; Delling G; Jürgens H; Kotz R; Salzer-Kuntschik M
Cancer Treat Res; 1993; 62():269-77. PubMed ID: 7682088
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study.
Winkler K; Beron G; Kotz R; Salzer-Kuntschik M; Beck J; Beck W; Brandeis W; Ebell W; Erttmann R; Göbel U
J Clin Oncol; 1984 Jun; 2(6):617-24. PubMed ID: 6202851
[TBL] [Abstract][Full Text] [Related]
6. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients].
Bielack S; Kempf-Bielack B; Schwenzer D; Birkfellner T; Delling G; Ewerbeck V; Exner GU; Fuchs N; Göbel U; Graf N; Heise U; Helmke K; von Hochstetter AR; Jürgens H; Maas R; Münchow N; Salzer-Kuntschik M; Treuner J; Veltmann U; Werner M; Winkelmann W; Zoubek A; Kotz R
Klin Padiatr; 1999; 211(4):260-70. PubMed ID: 10472560
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.
Meyers PA; Heller G; Healey J; Huvos A; Lane J; Marcove R; Applewhite A; Vlamis V; Rosen G
J Clin Oncol; 1992 Jan; 10(1):5-15. PubMed ID: 1370176
[TBL] [Abstract][Full Text] [Related]
8. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.
Rosen G; Caparros B; Huvos AG; Kosloff C; Nirenberg A; Cacavio A; Marcove RC; Lane JM; Mehta B; Urban C
Cancer; 1982 Mar; 49(6):1221-30. PubMed ID: 6174200
[TBL] [Abstract][Full Text] [Related]
9. Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.
Rosen G; Huvos AG; Marcove R; Nirenberg A
Clin Orthop Relat Res; 1986 Jun; (207):164-73. PubMed ID: 2424660
[TBL] [Abstract][Full Text] [Related]
10. Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma.
Rha SY; Chung HC; Gong SJ; Shim KY; Ahn JB; Yang WI; Shin KH; Yoo NC; Kim JH; Roh JK; Lee CI; Kim BS
Oncol Rep; 1999; 6(3):631-7. PubMed ID: 10203605
[TBL] [Abstract][Full Text] [Related]
11. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin.
Bacci G; Picci P; Ruggieri P; Mercuri M; Avella M; Capanna R; Brach Del Prever A; Mancini A; Gherlinzoni F; Padovani G
Cancer; 1990 Jun; 65(11):2539-53. PubMed ID: 2337871
[TBL] [Abstract][Full Text] [Related]
12. [Preoperative systemic chemotherapy of patients with osteosarcoma: a preliminary study of nine cases].
Chuman H; Fukuma H; Beppu Y
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1736-43. PubMed ID: 2471460
[TBL] [Abstract][Full Text] [Related]
13. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group.
Provisor AJ; Ettinger LJ; Nachman JB; Krailo MD; Makley JT; Yunis EJ; Huvos AG; Betcher DL; Baum ES; Kisker CT; Miser JS
J Clin Oncol; 1997 Jan; 15(1):76-84. PubMed ID: 8996127
[TBL] [Abstract][Full Text] [Related]
14. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin.
Bacci G; Picci P; Ferrari S; Ruggieri P; Casadei R; Tienghi A; Brach del Prever A; Gherlinzoni F; Mercuri M; Monti C
Cancer; 1993 Dec; 72(11):3227-38. PubMed ID: 8242546
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide.
Bacci G; Briccoli A; Ferrari S; Saeter G; Donati D; Longhi A; Manfrini M; Bertoni F; Rimondini S; Monti C; Forni C
Oncol Rep; 2000; 7(2):339-46. PubMed ID: 10671683
[TBL] [Abstract][Full Text] [Related]
16. Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study.
Saeter G; Alvegård TA; Elomaa I; Stenwig AE; Holmström T; Solheim OP
J Clin Oncol; 1991 Oct; 9(10):1766-75. PubMed ID: 1717666
[TBL] [Abstract][Full Text] [Related]
17. Influence of adriamycin dose in the outcome of patients with osteosarcoma treated with multidrug neoadjuvant chemotherapy: results of two sequential studies.
Bacci G; Picci P; Ferrari S; Casadei R; Brach Del Prever A; Tienghi A; Mancini A
J Chemother; 1993 Aug; 5(4):237-46. PubMed ID: 8229152
[TBL] [Abstract][Full Text] [Related]
18. [Neoadjuvant chemotherapy of osteosarcoma. Results of the cooperative studies COSS-80 and COSS-82 after 7 and 5 years].
Bielack S; Beck J; Delling G; Gerein V; Grümayer R; Hiddemann W; Jobke A; Jürgens H; Kornhuber G; Kotz R
Klin Padiatr; 1989; 201(4):275-84. PubMed ID: 2674532
[TBL] [Abstract][Full Text] [Related]
19. Adriamycin-methotrexate high dose versus adriamycin-methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities: a randomized study.
Bacci G; Gherlinzoni F; Picci P; Van Horn JR; Jaffe N; Guerra A; Ruggieri P; Biagini R; Capanna R; Toni A
Eur J Cancer Clin Oncol; 1986 Nov; 22(11):1337-45. PubMed ID: 3493903
[TBL] [Abstract][Full Text] [Related]
20. Intraarterial Cisplatin and intravenous adriamycin in nonmetastatic osteosarcoma of the extremities: a single institution experience in Taiwan.
Chiu TJ; Wang JW; Chen YJ; Tang Y; Huang CH
Chang Gung Med J; 2009; 32(1):72-80. PubMed ID: 19292942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
